VBI Vaccines Inc.

NASDAQ:VBIV   12:48:48 PM EDT
0.89
+0.03 (+3.50%)
Earnings Announcements

VBI Vaccines Reports First Quarter 2022 Financial Results

Published: 05/09/2022 13:48 GMT
VBI Vaccines Inc. (VBIV) - Vbi Vaccines Reports First Quarter 2022 Financial Results and Provides Corporate Update.
Q1 Revenue $100,000.
Q1 Loss per Share $0.08.
$101.3 Million in Cash at End of Q1 2022.
Revenue is expected to be $0.7 Million
Adjusted EPS is expected to be -$0.07

Next Quarter Revenue Guidance is expected to be $1.82 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.